McKesson agrees to invest in Option Care Health: what it means for McKesson stock

McKesson Corporation said on October 6, 2026, that it would invest approximately USD 1.40 billion for a minority interest in Option Care Health under a proposed transaction with Clayton, Dubilier & Rice. The announcement was published by McKesson Corporation.

Market context: Market report S&P 500.

The week in figures

McKesson’s October 6 announcement described a proposed investment for approximately 49 percent of Option Care Health, while Clayton, Dubilier & Rice would hold approximately 51 percent. The transaction values Option Care Health at approximately USD 5.80 billion and is expected to close in the first half of calendar year 2027, subject to customary closing conditions, stockholder approval and regulatory approvals. The figures and terms were disclosed in the McKesson release.

Chronology of the week

On October 1, 2026, McKesson announced an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032. The same release reaffirmed fiscal 2027 adjusted earnings-per-share guidance of USD 44.20 to USD 45.00 and a long-term adjusted earnings-per-share growth rate of 13 percent to 16 percent. McKesson Corporation published the details.

On October 6, 2026, McKesson and Clayton, Dubilier & Rice announced the proposed Option Care Health transaction. Option Care Health would remain separately managed, while McKesson would account for its minority interest using the equity method after closing, according to the company announcement.

Dates of the coming week

McKesson’s second-quarter fiscal 2027 earnings call is scheduled for November 4, 2026, according to the company’s October 1 release. The Option Care Health transaction is expected to close in the first half of calendar year 2027, subject to the stated approvals and other closing conditions.

The next price is shown from the start of trading by the continuously updated real-time quote of McKesson stock.